Literature DB >> 27485786

Adult and paediatric GERD: diagnosis, phenotypes and avoidance of excess treatments.

Kornilia Nikaki1, Philip Woodland1, Daniel Sifrim1.   

Abstract

Detailed investigations and objective measurements in patients with symptoms of gastro-oesophageal reflux should be performed with the intent of making the correct diagnosis, thus enabling choice of appropriate therapy. Establishing the most effective therapy is particularly important in adults who do not respond to standard treatment and in children. The use of PPIs for suspected GERD has increased substantially over the past decade, providing great relief in patients with acid-related symptoms, but also leading to adverse effects and a considerable economic burden. Adults with functional heartburn do not benefit from PPIs, while prolonged PPI use in patients with extraoesophageal symptoms remains a controversial area. Moreover, PPIs are not indicated in infants with GERD unless symptoms are proven to be acid-related. With regard to antireflux surgery, patients must be carefully selected to avoid the need for ongoing PPI treatment postoperatively. Correct diagnosis and phenotyping of patients with symptoms attributed to gastro-oesophageal reflux through detailed investigations is therefore imperative, leading to improved patient outcomes and rationalized use of available treatment options. In this Review, we outline currently available diagnostic tests and discuss approaches to limit any unnecessary medical or surgical interventions.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27485786     DOI: 10.1038/nrgastro.2016.109

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  160 in total

1.  Double-blind comparison [correction of Double-blind, placebo-controlled comparison] of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease. The European Rabeprazole Study Group.

Authors:  C P Dekkers; J A Beker; B Thjodleifsson; A Gabryelewicz; N E Bell; T J Humphries
Journal:  Aliment Pharmacol Ther       Date:  1999-01       Impact factor: 8.171

Review 2.  Co-morbidities in childhood Barrett's esophagus.

Authors:  E Hassall
Journal:  J Pediatr Gastroenterol Nutr       Date:  1997-09       Impact factor: 2.839

3.  Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease.

Authors:  Frank Zerbib; Kafia Belhocine; Mireille Simon; Maylis Capdepont; François Mion; Stanislas Bruley des Varannes; Jean-Paul Galmiche
Journal:  Gut       Date:  2011-10-13       Impact factor: 23.059

4.  Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn.

Authors:  Arne Kandulski; Jochen Weigt; Carlos Caro; Doerthe Jechorek; Thomas Wex; Peter Malfertheiner
Journal:  Clin Gastroenterol Hepatol       Date:  2014-12-09       Impact factor: 11.382

Review 5.  Systematic review: the extra-oesophageal symptoms of gastro-oesophageal reflux disease in children.

Authors:  V Tolia; Y Vandenplas
Journal:  Aliment Pharmacol Ther       Date:  2009-02-01       Impact factor: 8.171

Review 6.  Systematic review of patient-reported outcome instruments for gastroesophageal reflux disease symptoms.

Authors:  Nimish B Vakil; Katarina Halling; Anja Becher; Anna Rydén
Journal:  Eur J Gastroenterol Hepatol       Date:  2013-01       Impact factor: 2.566

7.  Aerophagia, gastric, and supragastric belching: a study using intraluminal electrical impedance monitoring.

Authors:  A J Bredenoord; B L A M Weusten; D Sifrim; R Timmer; A J P M Smout
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

8.  Wireless pH monitoring in patients with non-cardiac chest pain.

Authors:  Chandra Prakash; Ray E Clouse
Journal:  Am J Gastroenterol       Date:  2006-03       Impact factor: 10.864

9.  Esophageal impedance and esophagitis in children: any correlation?

Authors:  S Salvatore; B Hauser; T Devreker; S Arrigo; P Marino; C Citro; A Salvatoni; Y Vandenplas
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-11       Impact factor: 2.839

10.  A double-blind study of pantoprazole and omeprazole in the treatment of reflux oesophagitis: a multicentre trial.

Authors:  J Mössner; A H Hölscher; R Herz; A Schneider
Journal:  Aliment Pharmacol Ther       Date:  1995-06       Impact factor: 8.171

View more
  8 in total

1.  New Approaches to Gastroesophageal Reflux Disease.

Authors:  William Kethman; Mary Hawn
Journal:  J Gastrointest Surg       Date:  2017-06-16       Impact factor: 3.452

2.  Traditional Chinese medicine based on Tongjiang methodology combined with proton pump inhibitor (PPI) step-down in treating non-erosive reflux disease: a study protocol for a multicentered, randomized controlled clinical trial.

Authors:  Xia Li; Haomeng Wu; Beihua Zhang; Ting Chen; Xiaoshuang Shi; Jinxin Ma; Jiaqi Zhang; Xudong Tang; Fengyun Wang
Journal:  Trials       Date:  2022-10-18       Impact factor: 2.728

3.  Short-term safety and efficacy of peroral endoscopic myotomy for the treatment of achalasia in children.

Authors:  Zuqiang Liu; Yun Wang; Ying Fang; Ying Huang; Hongbin Yang; Xiaoxia Ren; Meidong Xu; Shiyao Chen; Weifeng Chen; Yunshi Zhong; Yiqun Zhang; Wenzheng Qin; Jianwei Hu; Mingyan Cai; Liqing Yao; Quanlin Li; Pinghong Zhou
Journal:  J Gastroenterol       Date:  2019-11-02       Impact factor: 7.527

Review 4.  Diagnostic Investigations of Gastroesophageal Reflux Disease: Who and When to Refer and for What Test?

Authors:  Arne Kandulski; Lukas Moleda; Martina Müller-Schilling
Journal:  Visc Med       Date:  2018-04-20

5.  Heartburn in children and adolescents in the presence of functional dyspepsia and/or irritable bowel syndrome correlates with the presence of sleep disturbances, anxiety, and depression.

Authors:  Jennifer M Colombo; Amanda D Deacy; Jennifer V Schurman; Craig A Friesen
Journal:  Medicine (Baltimore)       Date:  2021-04-02       Impact factor: 1.817

6.  Multichannel impedance monitoring for distinguishing nonerosive reflux esophagitis with minor changes on endoscopy in children.

Authors:  Fujino Junko; David Moore; Taher Omari; Grace Seiboth; Rammy Abu-Assi; Paul Hammond; Richard Couper
Journal:  Ther Adv Gastrointest Endosc       Date:  2021-07-15

Review 7.  Gastroesophageal Reflux Disease and Foregut Dysmotility in Children with Intestinal Failure.

Authors:  Anna Rybak; Aruna Sethuraman; Kornilia Nikaki; Jutta Koeglmeier; Keith Lindley; Osvaldo Borrelli
Journal:  Nutrients       Date:  2020-11-18       Impact factor: 5.717

8.  Acid Exposure Time > 6% Might Not Improve the Therapeutic Outcome in Chinese Gastroesophageal Reflux Disease Patients.

Authors:  Yuqing Lin; Yuwen Li; Mengya Liang; Niandi Tan; Mengyu Zhang; Songfeng Chen; Yinglian Xiao
Journal:  J Neurogastroenterol Motil       Date:  2021-01-30       Impact factor: 4.924

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.